The Road to Success ... Hard Knocks and All
CINCINNATI - I got a second chance, clearly.
Thats the way Kyle Combs, who graduates from UC with a BS in advanced medical imaging technology (AMIT) on Saturday, sums up his lifeall 23 years of it. But he is indeed wise, and strong in spirit beyond those years.
At 14, Combs was a freshman at
You just wake up in this hospital bed, Combs says of spending over a week in a coma and three and a half months in the hospital with a severe traumatic brain injury and partial paralysis.
That was the scariest time of my life, he says, recalling the grim prognosis of likely not being able to finish high school or being able to walk again on his own volition. Or, to be able to even tie his own shoes.
But where theres a will
Over the course of a year, Kyle underwent grueling physical therapy and regained all of his fine motor skills. He also graduated on time with his class, with honors, and applied to UCs very competitive AMIT program, a College of Allied Health Sciences degree in the the department of analytical and diagnostic sciences. On average 25 slots are available, with more than double the amount of applicants from all over the country.
I just went in with a goal and followed it straight though, Kyle says, as if barriers are naturally meant to be pushed to the wayside.
Coming into the program, Kyle possessed strong interpersonal skills, a commitment to his education and a focus and maturity beyond others his age, says program director Alan Vespie. He was the first student in the AMIT program's history to combine the nuclear medicine and sectional imaging modalities.
That dedication led him to an internship at
And, as Kyle approaches graduation, he does so with a smile and the eager willingness of someone who has overcome some of the heaviest barriers one can find to succeed.
I chose this profession because I felt a debt to the medical community...so many people participated in my rehabilitation.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.